In the BioHarmony Drug Report Database

"Preview" Icon

Betibeglogene autotemcel

Zynteglo (betibeglogene autotemcel) is a gene pharmaceutical. Betibeglogene autotemcel was first approved as Zynteglo on 2019-05-29. It has been approved in Europe to treat beta-thalassemia.

 

Trade Name

 

Zynteglo
 

Common Name

 

betibeglogene autotemcel
 

ChEMBL ID

 

CHEMBL4594311
 

Indication

 

beta-thalassemia
 

Drug Class

 

Image (chem structure or protein)

Betibeglogene autotemcel structure rendering